	Effectiveness and Safety of Anlotinib with or without PD-1 Blockades in Patients with Platinum-Resistant or Immunotherapy-Resistant Recurrent/Metastatic Nasopharyngeal Carcinoma: A Retrospective, Real-World Study. Drug Des Devel Ther Chen K, Li Y, Chen X, Zhu W, Shi Y, Ye X, Jiang C, Li Y, Liu F. PMID: 42415935 [PubMed - indexed for MEDLINE]
	Multimodal PET/CT Image Fusion-Derived Parameters and Biochemical Indices for Prognostic Monitoring in Nasopharyngeal Carcinoma: A Review. Br J Hosp Med (Lond) Hu Q, Kong L, Deng J. PMID: 42411517 [PubMed - indexed for MEDLINE]
	Prevalence and Clinical Findings of Nasopharyngeal Reflux in Patients With Idiopathic Nasal Symptoms: A Preliminary Study. J Otolaryngol Head Neck Surg Lechien JR. PMID: 42394145 [PubMed - indexed for MEDLINE]
	Epstein-Barr virus-driven immunosuppression in nasopharyngeal carcinoma: a comprehensive review of viral mechanisms, spatial tumor ecosystems, and precision therapeutics. Front Immunol Qu H, Zhang P, Tang Y, Chang T. PMID: 42389513 [PubMed - indexed for MEDLINE]
	Synthetic CT-enabled weekly adaptive radiotherapy for nasopharyngeal carcinoma: Optimizing plan adaptation triggers through volumetric-dosimetric monitoring. J Appl Clin Med Phys Cao Z, Wu C, Han L, Duan T, Zhang F, Zhang L, Wang B, Lei W, Ni X. PMID: 42385153 [PubMed - indexed for MEDLINE]
	Cross-Platform Gene Signature to Predict Survival Outcomes for Nasopharyngeal Carcinoma. JCO Precis Oncol Li H, Jing Q, Chow JCH, Cheuk W, Chan KSK, Hao S, Islam KA, Dai W, Lam KO, Lee VHF, Ng WT, Ngan RKC, Lee AWM, Wong JWH, Chiang CL. PMID: 42385107 [PubMed - indexed for MEDLINE]
	Clinical Analysis of Rotational-Translational Error Coupling in 3DoF Versus 6DoF CBCT Couch Corrections:A Cross-Sectional Study. Technol Cancer Res Treat Yi L, Li K, Zhong R, Yue H, Lu Z. PMID: 42305096 [PubMed - indexed for MEDLINE]
	The Prognostic Value of Serum Inflammatory Markers in Nasopharyngeal Carcinoma Patients Treated With Immune Checkpoint Inhibitors: A Multicenter Study. Cancer Med Xu Y, Xie J, Zhang D, Zhu L, Chen X, Zhang Q, Lv H, Chen K, Li L, Qu S, Chen X, Liu W, Zhu X. PMID: 42286988 [PubMed - indexed for MEDLINE]
	Immunotherapy plus induction chemotherapy followed by radiotherapy alone or one cycle of concurrent chemotherapy with cisplatin vs induction chemotherapy followed by two cycles of concurrent chemotherapy with cisplatin in locoregionally advanced nasopharyngeal carcinoma. Front Immunol Liang R, Li X, Zhu M, Lan F, Fu F, Lei L, Zou T, Ma L, Chen P, Luo L, Jin J, Zhang J. PMID: 42266699 [PubMed - indexed for MEDLINE]
	Oral microbiota associated with radiation-related caries among nasopharyngeal carcinoma patients following radiation therapy: analysis based on a longitudinal study. Support Care Cancer Zhang W, Chen W, Zhao L, Li X, Li Q, Hao X, Su Y, Zou L. PMID: 42265469 [PubMed - indexed for MEDLINE]
	Prognostic value of the monocyte-to-albumin ratio in nasopharyngeal carcinoma: A retrospective cohort study. Ann Acad Med Singap Ni WQ, Xu F, Lin YM, Long ZQ, Duan FF, Huang X, Xia W, Xie DH, Chen AQ, Du SS, Hua X. PMID: 42226677 [PubMed - indexed for MEDLINE]
	Longitudinal MRI Temporal Transformer Fusion Model for Predicting Induction Chemotherapy Efficacy in Locally Advanced Nasopharyngeal Carcinoma. Technol Cancer Res Treat Han L, Chen X, Zhao Z, Liu Y, Yu D, Zhang H, Ge F. PMID: 42224133 [PubMed - indexed for MEDLINE]
	The value of posttreatment (18)F-FDG PET/CT biomarkers for assessing response in metastatic nasopharyngeal carcinoma treated with PD-1 inhibitors. Eur J Radiol Xiao BB, Li XL, Gu LW, Liu C, Yu X, Zhang X, Tang LQ, Huang YY, Chen WH. PMID: 42208167 [PubMed - indexed for MEDLINE]
	A Host miRNA Signature Correlates With Clinical Stage Across Epstein-Barr Virus-Associated Malignancies. J Med Virol Xu Y, Min X, Zhang Y, Jiang S, Zhang Q, Zhang Z, Chen X, Wang X, Wang T, Yang C, Tong J, Zhu C, Wang Y, Robertson E, Tao R, Zhang L, Cai Q. PMID: 42198896 [PubMed - indexed for MEDLINE]
	Natural Killer (NK) Cells in Tumor Immunity: Limitations and Therapeutic Potential with a Focus on Nasopharyngeal Carcinoma and Comparison with T-Cell-Based Therapies. Cells Makowska A, Kontny U. PMID: 42193922 [PubMed - indexed for MEDLINE]
	Serum amyloid A kinetics predicts outcomes to PD-1 inhibitors in patients with recurrent or metastatic nasopharyngeal carcinoma. BMC Cancer Sun Z, Lin D, Liu Y, Li S, Chen J, Nie S, Zhang Y, Deng S, Long H, Yuan L, Tang L, Chen W, Zhao J. PMID: 42192349 [PubMed - indexed for MEDLINE]
	Epstein-Barr virus reprograms immune escape in nasopharyngeal carcinoma. Virulence Liu Q, Tong Y, Sun T, He L, Xu X, You K. PMID: 42186960 [PubMed - indexed for MEDLINE]
	Rare glandular tumors of the nasopharynx: A retrospective cohort study of papillary adenocarcinoma and salivary gland-type carcinomas. Medicine (Baltimore) Nguyen Van D, Dinh DN, Hoang Van N, Trung TT. PMID: 42175472 [PubMed - indexed for MEDLINE]
	Novel Anti-BNLF2b Antibody Screening and Early Detection of Nasopharyngeal Carcinoma. JAMA Otolaryngol Head Neck Surg Hsu WL, Tang J, Lam HY, Liu Z, Lam WKJ, Chan KH, Chang YL, Chen H, Cheng SH, Chien YC, Hsiao CK, Hua CH, Lee JC, Leu YS, Li F, Liao LJ, Lin CY, Liu J, Lou PJ, Terng SD, Tsai MH, Tsou YA, Wang CP, Wu MS, Yang TL, Yu KJ, Yu X, Chan KCA, Hildesheim A, Li T, Ji M, Chen CJ, GEV-NPC Study Group. PMID: 42166171 [PubMed - indexed for MEDLINE]
	Prognostic Value and Therapeutic Implications of MRI-Based Negative Lymph Nodes in Nasopharyngeal Carcinoma. Cancer Med Lin ZQ, He CY, He SQ, Dai DY, Yang KB, Li JB, Liu LZ, Huang Y, Zhang Y, Liu X, Ma J, Liu JN, Xu C. PMID: 42163833 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 9172

Page 1 of 459



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy